Aquadex was pivotal in the care of a 74-year-old patient with severe multi-organ complications (STEMI, catastrophic hypoxic respiratory failure, cardiogenic shock and multisystem organ failure).
Medical technology company to showcase Aquadex ultrafiltration therapy for fluid removal in Booth 530MINNEAPOLIS, April 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology ...
New release enhances usability and delivers more precise fluid management for pediatric patientsMINNEAPOLIS, April 21, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology ...
MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company committed to transforming the lives of people with fluid overload, is pleased to ...
MINNEAPOLIS, April 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that Detroit, Michigan-based health system, Henry Ford Health, has begun offering ultrafiltration therapy ...
APERION’s flagship product, SmartFlow, is an on-premises, Kubernetes-native AI governance control plane that was architecturally unaffected by the incident. SmartFlow is deployed as a software ...
RALEIGH, N.C., April 19, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), reported today that SurgiVision, Inc. ("SVI"), a privately held company and a leader in interventional ...
BEVERLY HILLS, Calif.--(BUSINESS WIRE)--SmartFlow Compliance Solutions (SCS), a leading cyber security company, announces the availability of SmartFlow Enterprise 2016, the latest release of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results